| |
| |
|
| Insider
Information: |
Cundy Kenneth C |
| Relationship: |
Chief Scientific Officer |
| City: |
Santa Clara |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
47,519 |
|
|
Indirect Shares
|
700 |
|
|
| Direct
Value |
$8,103 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
48,219 |
|
|
| Total
Value |
$8,103 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenoport Inc |
XNPT |
SVP, Preclinical Devel... |
2012-01-30 |
37,519 |
2010-02-24 |
700 |
Premium* |
|
|
Cohbar Inc |
CWBR |
Chief Scientific Officer |
2021-08-11 |
10,000 |
2015-05-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
131 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CWBR |
Cohbar Inc |
Chief Scientific Officer |
• – – |
2021-02-16 |
4 |
AS |
$1.90 |
$19,000 |
D/D |
(10,000) |
10,000 |
0 |
% |
|
| CWBR |
Cohbar Inc |
Chief Scientific Officer |
• – – |
2020-01-15 |
4 |
AS |
$1.91 |
$19,070 |
D/D |
(10,000) |
10,000 |
0 |
% |
|
| CWBR |
Cohbar Inc |
Chief Scientific Officer |
• – – |
2019-11-15 |
4 |
AS |
$1.92 |
$19,201 |
D/D |
(10,000) |
10,000 |
0 |
- |
|
| CWBR |
Cohbar Inc |
Chief Scientific Officer |
• – – |
2021-08-11 |
4 |
AS |
$2.01 |
$20,100 |
D/D |
(10,000) |
10,000 |
0 |
% |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2008-02-19 |
4 |
D |
$53.96 |
$20,127 |
D/D |
(373) |
16,945 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2009-06-11 |
4 |
AS |
$22.00 |
$22,000 |
D/D |
(1,000) |
13,792 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2009-10-06 |
4 |
AS |
$22.00 |
$22,000 |
D/D |
(1,000) |
13,792 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2009-07-01 |
4 |
AS |
$23.05 |
$23,282 |
D/D |
(1,000) |
13,792 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-02-01 |
4 |
AS |
$23.86 |
$24,036 |
D/D |
(1,000) |
56,211 |
0 |
- |
|
| CWBR |
Cohbar Inc |
Chief Scientific Officer |
• – – |
2020-06-15 |
4 |
AS |
$2.41 |
$24,100 |
D/D |
(10,000) |
10,000 |
0 |
% |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-01-03 |
4 |
AS |
$24.07 |
$24,303 |
D/D |
(1,000) |
57,211 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2009-09-17 |
4 |
AS |
$24.15 |
$24,631 |
D/D |
(1,000) |
13,792 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2006-12-22 |
4 |
AS |
$24.86 |
$25,008 |
D/D |
(1,000) |
58,211 |
0 |
- |
|
| XNPT |
Xenoport Inc |
officerTitle |
• – – |
2007-03-01 |
4 |
AS |
$24.96 |
$25,228 |
D/D |
(1,000) |
55,211 |
0 |
- |
|
| CWBR |
Cohbar Inc |
Chief Scientific Officer |
• – – |
2020-05-15 |
4 |
AS |
$2.56 |
$25,600 |
D/D |
(10,000) |
10,000 |
0 |
% |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2011-03-14 |
4 |
D |
$7.20 |
$26,726 |
D/D |
(3,712) |
25,862 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-04-02 |
4 |
AS |
$27.52 |
$27,806 |
D/D |
(1,000) |
54,211 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2007-04-25 |
4 |
AS |
$36.29 |
$34,096 |
D/D |
(900) |
53,311 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2009-01-14 |
4 |
D |
$26.97 |
$35,978 |
D/D |
(1,334) |
11,968 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2010-02-01 |
4 |
AS |
$18.30 |
$37,025 |
D/D |
(2,000) |
14,861 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2008-07-01 |
4 |
AS |
$37.78 |
$38,096 |
D/D |
(1,000) |
10,198 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2010-01-04 |
4 |
AS |
$18.75 |
$38,357 |
D/D |
(2,000) |
13,793 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2008-06-02 |
4 |
AS |
$41.65 |
$41,866 |
D/D |
(1,000) |
10,198 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2008-11-03 |
4 |
AS |
$41.12 |
$42,015 |
D/D |
(1,000) |
10,198 |
0 |
- |
|
| XNPT |
Xenoport Inc |
SVP, Preclinical Development |
• – – |
2008-04-01 |
4 |
AS |
$41.47 |
$42,087 |
D/D |
(1,000) |
12,945 |
0 |
- |
|
131 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
